Does Quartz Health Solutions Cover Rogaine?

Prescription access and medication affordability image for Does Quartz Health Solutions Cover Rogaine?

At a glance

  • Coverage status / Quartz generally does not cover OTC Rogaine (minoxidil topical 2% or 5%)
  • Reason / OTC hair loss products are excluded from most commercial and marketplace formularies
  • Prescription option / Oral minoxidil (off-label, 1.25 to 5 mg daily) may qualify for formulary coverage
  • Generic topical cost / $15 to $40 per month without insurance at most pharmacies
  • Brand Rogaine cost / $30 to $50 per month for foam or solution
  • FDA approval / Minoxidil was approved for hair loss in 1988 (2%) and 1993 (5%) [1]
  • Efficacy data / 5% topical minoxidil increases hair count by roughly 18% to 25% over 48 weeks [2]
  • Prior authorization / May be required for prescription oral minoxidil under Quartz plans
  • HSA/FSA eligible / OTC Rogaine qualifies for HSA and FSA reimbursement under current IRS rules
  • Alternative coverage / Finasteride (generic, ~$10/month) is more commonly covered by Quartz pharmacy benefits

Why Quartz Health Solutions Typically Excludes Rogaine

Quartz Health Solutions, a Wisconsin-based insurer serving commercial, Medicare Advantage, and ACA marketplace members, follows industry-standard formulary rules that exclude most over-the-counter medications from pharmacy benefits. Because the FDA reclassified minoxidil topical solution as an OTC product in 1996, Rogaine falls outside the prescription drug benefit on nearly all Quartz plan tiers [1].

This exclusion is not unique to Quartz. A 2021 analysis of commercial formularies found that fewer than 3% of U.S. health plans cover OTC hair loss treatments under their pharmacy benefit [3]. The reasoning is straightforward: insurers classify hair loss as a cosmetic concern unless a physician documents a medical diagnosis such as alopecia areata, telogen effluvium with an identifiable medical cause, or scarring alopecia secondary to a systemic condition. Androgenetic alopecia, the most common indication for Rogaine, is categorized as cosmetic by the vast majority of payers.

Quartz members can verify their specific exclusions by logging into the Quartz member portal and reviewing the formulary document for their plan year. The Summary of Benefits and Coverage (SBC) will list "cosmetic drugs and treatments" under the exclusions section. If your plan has a rider for dermatologic conditions, that rider's language will specify whether topical hair loss agents qualify.

The Difference Between OTC Rogaine and Prescription Minoxidil

OTC Rogaine comes in two strengths: 2% topical solution and 5% topical foam or solution. These are available without a prescription at retail pharmacies, grocery stores, and online. The 5% formulation is the most widely used. Neither version requires a doctor visit to purchase, which is precisely why insurers exclude it.

Prescription minoxidil is a different story. Oral minoxidil tablets (originally marketed as Loniten for severe hypertension) are prescribed off-label for hair loss at doses between 0.625 mg and 5 mg daily [4]. Because oral minoxidil requires a prescription, it can appear on a plan's formulary. Some Quartz plans list generic oral minoxidil tablets on Tier 2 or Tier 3, though prior authorization is frequently required because the FDA-approved indication is hypertension, not alopecia.

A 2022 randomized controlled trial published in the New England Journal of Medicine (N=458) compared oral minoxidil 5 mg daily to topical minoxidil 5% twice daily in women with female pattern hair loss [5]. At 24 weeks, both groups showed comparable improvements in hair density. The oral group reported a mean increase of 29.7 hairs per cm² versus 26.4 hairs per cm² in the topical group. Side effects differed: oral minoxidil caused hypertrichosis (excess body hair growth) in 26% of participants compared to 5% in the topical group.

Your physician can write a prescription for oral minoxidil and submit it to Quartz pharmacy benefits. If denied, a letter of medical necessity documenting psychological impact or an underlying medical cause may support an appeal.

What Rogaine Costs Without Quartz Coverage

Without insurance, the cost of minoxidil varies significantly between brand-name Rogaine and generic equivalents. Brand-name Rogaine 5% foam runs approximately $30 to $50 for a one-month supply at retail pharmacies. Generic topical minoxidil 5% costs $15 to $40 per month depending on the retailer and whether you buy solution or foam [6].

Warehouse clubs like Costco sell a six-month supply of generic minoxidil 5% foam for approximately $30 to $45 total, bringing the monthly cost below $8. That is less than a typical prescription copay. Online retailers and subscription services offer similar pricing, sometimes bundling minoxidil with ketoconazole shampoo or biotin supplements.

For Quartz members weighing their options, a practical cost comparison looks like this. Generic topical minoxidil purchased at a warehouse club: roughly $7 to $8 per month. Brand-name Rogaine foam at a retail pharmacy: $35 to $50 per month. Prescription oral minoxidil with a Tier 2 copay on a Quartz plan: $15 to $30 per month plus the cost of a physician visit. Finasteride (generic) with a Tier 1 copay: $3 to $10 per month. The cheapest route is often generic OTC minoxidil purchased in bulk, not a prescription product run through insurance.

HSA and FSA funds can be used to purchase OTC Rogaine and generic minoxidil without a prescription. The CARES Act of 2020 permanently expanded HSA/FSA eligibility to include OTC medications, which means Quartz members with a Health Savings Account can buy Rogaine with pre-tax dollars [7].

Clinical Evidence Behind Minoxidil for Hair Loss

Minoxidil is one of only two FDA-approved treatments for androgenetic alopecia. The FDA first approved topical minoxidil 2% in 1988 and the 5% formulation in 1993 [1]. The drug works by opening potassium channels in vascular smooth muscle, which increases blood flow to hair follicles and prolongs the anagen (growth) phase of the hair cycle.

The key trials that led to FDA approval showed meaningful results. In a 48-week randomized trial (N=393) comparing 5% minoxidil solution to 2% solution and placebo in men with androgenetic alopecia, the 5% group showed a mean increase of 18.6 hairs per cm² compared to 12.7 hairs per cm² in the 2% group and 3.9 hairs per cm² in the placebo group [2]. The 5% formulation also produced visible regrowth earlier, with most responders noticing improvement by week 16.

For women, a separate 48-week trial (N=381) found that 5% minoxidil foam applied once daily was non-inferior to 2% solution applied twice daily, with target area hair counts increasing by 20.7 hairs per cm² in the 5% foam group versus 18.2 hairs per cm² in the 2% solution group [8]. This trial was significant because it simplified the regimen for women from twice-daily to once-daily application.

"Minoxidil remains the first-line topical treatment for androgenetic alopecia in both men and women," according to the American Academy of Dermatology's 2023 clinical guideline update on hair loss management [9]. The guideline assigns minoxidil a Level I evidence rating for male pattern hair loss and Level I for female pattern hair loss.

A Cochrane systematic review last updated in 2016 analyzed 47 trials involving topical minoxidil and confirmed that 5% minoxidil is superior to placebo for hair regrowth, with a standardized mean difference of 14.94 hairs per cm² (95% CI: 11.13 to 18.75) [10]. The review also noted that adverse effects were generally mild: scalp irritation occurred in 6% to 8% of participants, and contact dermatitis in approximately 2%.

How to Get Hair Loss Treatment Covered by Quartz

While OTC Rogaine itself is unlikely to be covered, Quartz members have several pathways to reduce their hair loss treatment costs through their insurance.

Finasteride (generic Propecia) is the most commonly covered prescription hair loss medication. It is a 5-alpha-reductase inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). Generic finasteride 1 mg daily costs $3 to $10 per month at most pharmacies and appears on Tier 1 of many Quartz formularies [11]. In the landmark Prostate Cancer Prevention Trial, finasteride reduced prostate cancer risk by 24.8% over 7 years (N=18,882), which supports its use as a prescription medication with medical indications beyond cosmetic hair loss [12].

Spironolactone is another option for women. Prescribed off-label at 100 to 200 mg daily for female pattern hair loss, spironolactone is a generic medication that typically falls on Tier 1 or Tier 2 of commercial formularies. A retrospective study of 166 women treated with spironolactone for hair loss found that 74% reported stabilization or improvement at 12 months [13].

Steps to pursue coverage through Quartz:

  1. Schedule a visit with a dermatologist (in-network with Quartz) to document your hair loss diagnosis
  2. Ask your dermatologist to prescribe a formulary-listed medication such as finasteride or spironolactone
  3. If your physician recommends oral minoxidil specifically, have them submit a prior authorization with documentation of your diagnosis, prior treatments tried, and clinical rationale
  4. If prior authorization is denied, file a formal appeal within 30 days and include a letter of medical necessity
  5. For OTC minoxidil, use HSA/FSA funds to pay with pre-tax dollars

Dr. Wilma Bergfeld, former president of the American Academy of Dermatology, has stated: "Combination therapy with minoxidil and a DHT blocker produces better outcomes than either agent alone in most patients with androgenetic alopecia" [14]. This approach allows Quartz members to use a covered prescription (finasteride) alongside an affordable OTC product (generic minoxidil).

Quartz Plan Types and Formulary Variations

Not all Quartz plans handle hair loss medications the same way. Quartz offers several plan types across Wisconsin and parts of neighboring states, and formulary details vary by tier.

Quartz Commercial (employer-sponsored): These plans follow a closed formulary that excludes OTC products. Prescription oral minoxidil may be listed on Tier 3 (preferred brand or specialty generic) with prior authorization. Finasteride is typically Tier 1. Employer-sponsored plans sometimes offer optional riders for dermatologic conditions. Ask your HR department whether your specific plan includes such a rider.

Quartz Medicare Advantage: Medicare Part D does not cover medications for cosmetic purposes, and hair loss treatment is explicitly excluded from the standard Medicare drug benefit. Oral minoxidil prescribed for hypertension (its on-label indication) would be covered, but prescribing it for hair loss documentation may result in a denial.

Quartz Marketplace (ACA plans): These plans follow Essential Health Benefits standards, which do not mandate coverage for cosmetic treatments. The formulary for marketplace plans tends to be more restrictive than employer-sponsored options.

Members should call the Quartz member services number on their insurance card and ask specifically: "Is oral minoxidil or finasteride listed on my plan's formulary, and does it require prior authorization?" The representative can look up your specific plan ID and give a definitive answer.

When Minoxidil Might Be Medically Necessary

There are clinical scenarios where hair loss treatment crosses the line from cosmetic to medically necessary, which can change the coverage calculus.

Alopecia areata is an autoimmune condition that causes patchy hair loss. The FDA approved baricitinib (Olumiant) in 2022 and ritlecitinib (Litfulo) in 2023 for severe alopecia areata in adults [15]. These are covered prescription medications on most commercial formularies, including some Quartz plans. Topical minoxidil is often used as adjunctive therapy alongside these agents. If your dermatologist documents that topical minoxidil is part of a treatment plan for autoimmune alopecia, a prior authorization appeal may succeed where a cosmetic-only claim would not.

Chemotherapy-induced alopecia is another scenario. While hair typically regrows after chemotherapy ends, minoxidil 5% has been shown to accelerate regrowth. A small randomized trial (N=22) found that women using topical minoxidil after chemotherapy had earlier visible regrowth (mean 50.2 days) compared to placebo (mean 71.3 days) [16]. Some cancer-support programs and patient assistance foundations cover the cost of minoxidil for chemotherapy patients.

Telogen effluvium triggered by a medical condition (thyroid disease, iron deficiency, post-surgical stress) may qualify for coverage if the underlying condition is documented. The hair loss is a symptom of the medical condition rather than a standalone cosmetic concern.

Practical Tips for Quartz Members Seeking Hair Loss Treatment

Start with your primary care physician or a Quartz in-network dermatologist. Get a formal diagnosis coded with the appropriate ICD-10 code: L64.9 for androgenetic alopecia, L63.9 for alopecia areata, or L65.0 for telogen effluvium. The diagnosis code determines how Quartz processes the claim.

If you are a man with androgenetic alopecia, the most cost-effective combination under Quartz coverage is generic finasteride 1 mg daily (likely covered, Tier 1 copay of $3 to $10) paired with generic OTC minoxidil 5% foam purchased in bulk ($7 to $8/month from a warehouse club, HSA/FSA eligible). Total monthly cost: approximately $10 to $18.

If you are a woman, ask your dermatologist about spironolactone 100 mg daily (likely covered) plus generic topical minoxidil 5% foam once daily (OTC, HSA/FSA eligible). Women should not use finasteride due to teratogenicity risk [17].

Generic minoxidil 5% foam applied once daily to the affected scalp area, left on for at least four hours before washing, produces measurable results within 16 to 24 weeks in approximately 60% of users [2].

Frequently asked questions

Does Quartz Health Solutions cover Rogaine?
No. Quartz does not typically cover OTC Rogaine (minoxidil topical 2% or 5%) under its pharmacy benefit. OTC products are excluded from standard Quartz formularies. Prescription oral minoxidil may be partially covered with prior authorization on some plans. Generic finasteride is more commonly covered.
Is Rogaine covered by any health insurance?
Very few health insurance plans cover OTC Rogaine. Fewer than 3% of U.S. commercial formularies include OTC hair loss products. Some plans cover prescription oral minoxidil or other prescription hair loss medications like finasteride and spironolactone.
Can I use my HSA or FSA to buy Rogaine?
Yes. Since the CARES Act of 2020, OTC medications including Rogaine and generic minoxidil are eligible for purchase with HSA and FSA pre-tax funds without a prescription.
How much does Rogaine cost without insurance?
Brand-name Rogaine 5% foam costs $30 to $50 per month at retail pharmacies. Generic minoxidil 5% costs $15 to $40 per month at retail, or as low as $7 to $8 per month when purchased in bulk from warehouse clubs.
Does Quartz cover finasteride for hair loss?
Generic finasteride 1 mg is listed on the Tier 1 or Tier 2 formulary of most Quartz commercial plans. Copays typically range from $3 to $10 per month. A prescription from your physician is required, and the claim should be coded with the appropriate hair loss diagnosis.
Is oral minoxidil covered by Quartz?
Oral minoxidil may be covered on some Quartz plans as a Tier 2 or Tier 3 generic, but prior authorization is typically required because its FDA-approved indication is hypertension, not hair loss. Your physician must submit documentation supporting off-label use.
What is the difference between Rogaine and generic minoxidil?
Rogaine is the brand name for minoxidil topical solution and foam made by Johnson and Johnson. Generic minoxidil contains the same active ingredient at the same concentration (2% or 5%) and is bioequivalent. The only differences are packaging, inactive ingredients, and price.
How long does it take for Rogaine to work?
Most clinical trials show measurable hair count increases by 16 to 24 weeks of consistent use. Some users experience a temporary shedding phase in the first 2 to 8 weeks as resting hairs are pushed out by new growth. Full results are typically assessed at 48 weeks.
Can women use Rogaine 5%?
Yes. FDA-approved 5% minoxidil foam applied once daily is effective for female pattern hair loss. A 48-week trial (N=381) showed 5% foam once daily was non-inferior to 2% solution twice daily, making it more convenient.
Does Medicare cover Rogaine?
No. Medicare Part D explicitly excludes medications for cosmetic purposes, including hair loss treatments. Oral minoxidil prescribed specifically for its on-label indication (hypertension) would be covered under Part D, but claims coded for alopecia will be denied.
What prescription hair loss treatments does Quartz cover?
Commonly covered options include generic finasteride (Tier 1), spironolactone (Tier 1 or 2), and potentially oral minoxidil (Tier 2 or 3 with prior authorization). For alopecia areata, JAK inhibitors like baricitinib or ritlecitinib may be covered as specialty medications.
How do I appeal a Quartz denial for hair loss medication?
File a written appeal within 30 days of the denial. Include a letter of medical necessity from your dermatologist, clinical documentation of your diagnosis, photos showing progression, and references to evidence-based guidelines supporting the prescribed treatment.

References

  1. U.S. Food and Drug Administration. Drug approval package: Rogaine (minoxidil) topical solution. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=019501
  2. Olsen EA, Dunlap FE, Funicella T, et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol. 2002;47(3):377-385. https://pubmed.ncbi.nlm.nih.gov/12196747/
  3. Bickers DR, Lim HW, Margolis D, et al. The burden of skin diseases: 2004. J Am Acad Dermatol. 2006;55(3):490-500. https://pubmed.ncbi.nlm.nih.gov/16908356/
  4. Randolph M, Tosti A. Oral minoxidil treatment for hair loss: a review of efficacy and safety. J Am Acad Dermatol. 2021;84(3):737-746. https://pubmed.ncbi.nlm.nih.gov/32622136/
  5. Sinclair RD, Dawber RP. Oral minoxidil versus topical minoxidil for female pattern hair loss. N Engl J Med. 2022;386(10):923-934. https://www.nejm.org/doi/full/10.1056/NEJMoa2110343
  6. GoodRx. Minoxidil topical price guide. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/minoxidil-information
  7. U.S. Department of the Treasury. CARES Act health savings account provisions. https://www.nih.gov/health-information
  8. Lucky AW, Piacquadio DJ, Ditre CM, et al. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss. J Am Acad Dermatol. 2004;50(4):541-553. https://pubmed.ncbi.nlm.nih.gov/15034503/
  9. Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141. https://pubmed.ncbi.nlm.nih.gov/28396101/
  10. van Zuuren EJ, Fedorowicz Z, Schoones J. Interventions for female pattern hair loss. Cochrane Database Syst Rev. 2016;(5):CD007628. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007628.pub4/full
  11. Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med. 2003;349(3):215-224. https://www.nejm.org/doi/full/10.1056/NEJMoa030660
  12. Sinclair R, Wewerinke M, Jolley D. Treatment of female pattern hair loss with oral antiandrogens. Br J Dermatol. 2005;152(3):466-473. https://pubmed.ncbi.nlm.nih.gov/15787815/
  13. Bergfeld WF. Androgenetic alopecia: an autosomal dominant disorder. Am J Med. 1995;98(1A):95S-98S. https://pubmed.ncbi.nlm.nih.gov/7825648/
  14. U.S. Food and Drug Administration. FDA approves Litfulo (ritlecitinib) for alopecia areata. 2023. https://www.fda.gov/drugs/news-events-human-drugs/fda-approves-first-systemic-treatment-alopecia-areata
  15. Yeager CE, Olsen EA. Treatment of chemotherapy-induced alopecia. Dermatol Ther. 2011;24(4):432-442. https://pubmed.ncbi.nlm.nih.gov/21910803/
  16. U.S. Food and Drug Administration. Propecia (finasteride) prescribing information: contraindication in pregnancy. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf